Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PLI schemes across sectors attracted significant investments by December 2023, notably in pharma and solar industries. While some sectors thrived, others like IT hardware, auto, and textiles faced tepid interest, prompting a review for scheme improvements.
Sandeep Raina is not worried about the market crash. Further small cuts are possible, but it's not a bloodbath. Stay invested, the market will revive. Quality midcaps, smallcaps, and largecaps with 20% growth, good ROCE, and cash flows are worth investing. Pharma stocks like Beta Drugs, Kilpest, and Sun Pharma are interesting.
Meghana Malkan believes realty and pharma sectors show potential for trade. She highlights specific stocks to watch, cautions about weak resistance for Nifty, predicts a drop in Bank Nifty, takes a break from PSU sector, and has a mixed view on the IT sector. In the case of IT, she would prefer to really adopt a wait-and-watch approach.
Indian pharma industry's heavy dependence on imports for active pharmaceutical ingredients (API), key starting materials (KSM) and basic chemicals has been rather alarming, highlighting the need for a resolution.
Market access in Russia is complex due to diverse channels and language barriers.